Clinical Trials List
2024-01-01 - 2027-12-31
Phase III
Recruiting4
ICD-10C43.0
Malignant melanoma of lip
ICD-10D03.0
Melanoma in situ of lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9172.0
Malignant melanoma of skin of lip
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzeon-jye Chiou Division of Hematology & Oncology
- Tzu-Yao Liao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- TSU-YI CHAO Division of Hematology & Oncology
- 莊博雅 Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- 蔡承志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chen-Yuan Lin Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
620 participants
